XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Public Offering
4SC Royalty Settlement
Common Stock
Common Stock
Public Offering
Common Stock
4SC Royalty Settlement
Additional Paid-In Capital
Additional Paid-In Capital
Public Offering
Additional Paid-In Capital
4SC Royalty Settlement
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020       21,168,240              
Beginning balance at Dec. 31, 2020 $ 158,785     $ 2     $ 266,823     $ (4,112) $ (103,928)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (34,534)                   (34,534)
Stock-based compensation 1,579           1,579        
Foreign exchange translation adjustment 2,991                 2,991  
Issuance of common stock (in shares)           581,199          
Issuance of common stock     $ 8,625           $ 8,625    
Ending balance (in shares) at Mar. 31, 2021       21,749,439              
Ending balance at Mar. 31, 2021 137,446     $ 2     277,027     (1,121) (138,462)
Beginning balance (in shares) at Dec. 31, 2020       21,168,240              
Beginning balance at Dec. 31, 2020 158,785     $ 2     266,823     (4,112) (103,928)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (52,468)                    
Ending balance (in shares) at Jun. 30, 2021       21,749,439              
Ending balance at Jun. 30, 2021 120,742     $ 2     278,534     (1,398) (156,396)
Beginning balance (in shares) at Mar. 31, 2021       21,749,439              
Beginning balance at Mar. 31, 2021 137,446     $ 2     277,027     (1,121) (138,462)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (17,934)                   (17,934)
Stock-based compensation 1,507           1,507        
Foreign exchange translation adjustment (277)                 (277)  
Ending balance (in shares) at Jun. 30, 2021       21,749,439              
Ending balance at Jun. 30, 2021 120,742     $ 2     278,534     (1,398) (156,396)
Beginning balance (in shares) at Dec. 31, 2021       26,335,418              
Beginning balance at Dec. 31, 2021 127,115     $ 3     324,237     (252) (196,873)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (20,808)                   (20,808)
Stock-based compensation 2,069           2,069        
Foreign exchange translation adjustment (58)                 (58)  
Issuance of common stock (in shares)       852 2,904,113            
Issuance of common stock 5 $ 29,638         5 $ 29,638      
Ending balance (in shares) at Mar. 31, 2022       29,240,383              
Ending balance at Mar. 31, 2022 137,961     $ 3     355,949     (310) (217,681)
Beginning balance (in shares) at Dec. 31, 2021       26,335,418              
Beginning balance at Dec. 31, 2021 127,115     $ 3     324,237     (252) (196,873)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (42,709)                    
Ending balance (in shares) at Jun. 30, 2022       30,564,995              
Ending balance at Jun. 30, 2022 127,848     $ 3     368,087     (660) (239,582)
Beginning balance (in shares) at Mar. 31, 2022       29,240,383              
Beginning balance at Mar. 31, 2022 137,961     $ 3     355,949     (310) (217,681)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (21,901)                   (21,901)
Stock-based compensation 2,062           2,062        
Foreign exchange translation adjustment (350)                 (350)  
Issuance of common stock (in shares)       24,612 1,300,000            
Issuance of common stock 130 $ 9,946         130 $ 9,946      
Ending balance (in shares) at Jun. 30, 2022       30,564,995              
Ending balance at Jun. 30, 2022 $ 127,848     $ 3     $ 368,087     $ (660) $ (239,582)